Skip to main content

Table 7 Efficacy parameters

From: A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

  BM-MSC arm Placebo  
  Baseline 6 months Baseline 6 months Difference P value
Rest pain (Median) 3 1 3 0 −1.00 0.1099*
ABPI Mean (SD) 0.554 (0.26) 0.768 (0.15) 0.592 (0.23) 0.596 (0.14) −0.17 0.0018
  1. *Kruskal-Wallis test.
  2. ANOVA.
\